在股东批准之后,Caladrius董事会批准了Caladrius普通股的反向股票拆分,比例为每15股发行在外的股票换1股新股。
合并后的公司将更名为...查看全文
牛股小红书2022-04-28 13:52
临床阶段生物技术公司$Caladrius生物科学(CLBS)$ 与私营企业Cend Therapeutics达成的合并协议。
根据协议条款,Cend将与Caladrius(CLBS)的一个子公司进行全股票交易合并,合并后的公司Lisata Therapeutics将在纳斯达克上市,股票代码为“LSTA”
因此,卡拉德里乌斯(CLBS)首席执行官戴...查看全文
Edward16992021-02-19 19:25
$Caladrius生物科学(CLBS)$ 两个产品一个在日本的phase 2,一个在美国的phase 2b。很大的upside potential。查看全文
Richardlim2021-01-21 02:07
$Tengasco(TGC)$ 起飞了?
向前辈学习 $Obalon Therapeutics(OBLN)$ $Caladrius生物科学(CLBS)$查看全文
$Caladrius Biosciences, Inc.(CLBS)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-03-23 AccNo: 0001104659-17-018804 Size: 97 KB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 8-K - Current report Filed: 2017-03-23 AccNo: 0000320017-17-000025 Size: 22 KBItem 8.01: Other Events 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-03-22 AccNo: 0000320017-17-000023 Size: 5 MB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 8-K - Current report Filed: 2017-03-22 AccNo: 0000320017-17-000022 Size: 5 MBItem 1.02: Termination of a Material Definitive AgreementItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-03-20 AccNo: 0000320017-17-000017 Size: 107 KB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-03-17 AccNo: 0001571049-17-002575 Size: 2 MB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-03-17 AccNo: 0001571049-17-002520 Size: 850 KB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 8-K - Current report Filed: 2017-03-17 AccNo: 0001571049-17-002519 Size: 850 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer...
$Caladrius Biosciences, Inc.(CLBS)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-03-17 AccNo: 0001571049-17-002518 Size: 850 KB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 8-K - Current report Filed: 2017-03-17 AccNo: 0001571049-17-002517 Size: 850 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer...